Xuenou > Popular > FDA panel backs much-debated ALS drug in rare, 2nd review
FDA panel backs much-debated ALS drug in rare, 2nd review
A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease

FDA panel backs much-debated ALS drug in rare, 2nd review

A panel of federal health advisers has voted to recommend approval for an experimental drug to treat Lou Gehrig’s disease